NAFLD Among Patients With Type 2 Diabetes and CKD

NCT03826381 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease
Chronic Kidney Diseases
Type2 Diabetes

Interventions

DIAGNOSTIC_TEST: Magnetic resonance (MR) spectroscopy of the liver
DIAGNOSTIC_TEST: Fibroscan
DEVICE: Continuous glucose monitoring (CGM) for four days.
RADIATION: Dual Energy X-ray Absorptiometry (DEXA) scan
BIOLOGICAL: Blood samples
OTHER: Clinical and demographic data

Sponsor

Rigshospitalet, Denmark